Fuse Science, Inc.

DROP

US36113J3041

Aerospace & Defense

Market Closed - OTC Markets Other stock markets 12:05:18 02/07/2024 am IST			5-day change	1st Jan Change
0.01 ^USD	-19.29%		-19.35%	+6.38%

2021	Fuse Science, Inc. Announces Executive Changes	CI
2016	David Rector Resigns as Member of Board of Directors of Fuse Science, Inc. and from His Positions as CEO, CFO and All Other Officer Positions	CI

Fuse Science, Inc. and Macular Health, LLC Advance Commercial Formula into Clinical Study for AMD Sufferers

January 15, 2013 at 07:31 pm IST

Fuse Science, Inc. announced that in furtherance of its planned licensing relationship with Macular Health, LLC, Fuse Science has developed a DROP formulation of Macular Health's macular degeneration nutritional supplement (currently marketed in capsule form) for immediate clinical studies in conjunction with Macular Health. The clinical study will follow the same Multifocal Electroretinogram protocol that Macular Health used at the UAB Callahan Eye Foundation Hospital in Birmingham, Alabama, by John O. Mason, III., M.D., using their capsule formula. MERG researchers reported that the study established benefits for people taking Macular Health's capsule formulation, with an average of 16% improvement in retina function in only 12 weeks and 17% improvement in retina function after two years of taking the Macular Health supplement.

Latest news about Fuse Science, Inc.

Fuse Science, Inc. Announces Executive Changes	12/21/12	CI
David Rector Resigns as Member of Board of Directors of Fuse Science, Inc. and from His Positions as CEO, CFO and All Other Officer Positions	11/16/11	CI
Exactus BioSolutions, Inc. acquired Spiral Energy Tech., Inc. in a reverse merger transaction.	04/16/04	CI
Fuse Science, Inc. Announces Management Changes	05/16/05	CI
Gelvin Stevenson Resigns as a Member of Board of Directors of Fuse Science, Inc	04/15/04	CI
Fuse Science, Inc. Auditor Raises 'Going Concern' Doubt	16/15/16	CI
Fuse Science, Inc. (OTCPK:DROP.D) acquired 51% stake in Spiral Energy Tech., Inc. for $49.5 million.	06/14/06	CI
Fuse Science, Inc. announced that it has received $0.02 million in funding.	25/14/25	CI
Fuse Science, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2013	27/14/27	CI
Fuse Science, Inc. Reports Earnings Results for the Year Ended September 30, 2013	22/14/22	CI
Fuse Science, Inc. Auditor Raises 'Going Concern' Doubt	22/14/22	CI
Fuse Science, Inc. announced that it expects to receive $1 million in funding from GRQ Consultants, Inc. 401K Plan and Hudson Bay Capital Management LP.	03/14/03	CI
Fuse Science, Inc. Announces Demise of its Member of Board and Chairperson of the Compensation Committee, James T. Frederick	06/13/06	CI
Fuse Science, Inc. Updates on the Introduction of Macular's Health's New MacuDrop AREDS II Formula Containing Fuse Science(R) Technology	21/13/21	CI
Fuse Science, Inc. announced that it has received $0.70 million in funding from Melechdavid, Inc., Muscle Pharm Corp., Frost Gamma Investments Trust, and other investors.	08/13/08	CI
Fuse Science, Inc. announced that it expects to receive $0.70 million in funding from Melechdavid, Inc., Muscle Pharm Corp., Frost Gamma Investments Trust, and other investors.	07/13/07	CI
Fuse Science, Inc. Set to Unveil Next Generation Commercial Advertising Leveraging World Class Athletes	10/13/10	CI
Fuse Science, Inc. Announces Executive and Board Changes	20/13/20	CI
Fuse Science, Inc. Announces Executive Changes	17/13/17	CI
Fuse Science, Inc. Announces Revenue Results for the Third Quarter and Nine Months Ended June 30, 2013	16/13/16	CI
Fuse Science, Inc. Announces Round II Research Offers Major Advancements in Delivery of Active Pharmaceutical Ingredients	04/13/04	CI
Fuse Science, Inc. and Macular Health, LLC Advance Commercial Development of AREDS2 Drop Formulation	23/13/23	CI
Fuse Science, Inc. Adds Walgreen Co. as Distributor	09/13/09	CI
Fuse Science, Inc. Expands Retail Distribution to Golf Galaxy Stores	08/13/08	CI
Fuse Science, Inc. Expands Retail Distribution of Powered by Fuse(R) to Kinney Drugs(TM)	15/13/15	CI

Chart Fuse Science, Inc.

Duration

Period

More charts

Company Profile

Fuse Science, Inc. is engaged in developing and commercializing its SkyPorts drone support technology and Energy Demand Network (EDEN). This technology enables the long distance flight required for drone-based commerce without the need for drones to return home every 15 minutes to recharge. The technology allows a drone operator to travel many miles outside of its home range allowing for a flight path of numerous miles limited only by its EDEN network of SkyPorts. The Company is also involved in developing and commercializing XTRAX remote monitoring systems. The range of applications include from agricultural inspections and monitoring to pharmacy and fast food deliveries. The Company has not generated any revenue.

Sector

Aerospace & Defense

More about the company